<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="openVirus\examples\priya950\4-part\PMC7232498\results\search\disease\results.xml">
  <result pre="circulating strains of IBV in Uruguay. A subset of positive" exact="influenza" post="B samples from influenza-like illness (ILI) outpatients and severe"/>
  <result pre="patients between 5–14 years constituted the majority (33%) of all" exact="influenza" post="B infection (p &amp;lt; 0.05). Interestingly, we found that"/>
  <result pre="individuals &amp;gt;25 years were particularly vulnerable to Yamagata lineage infections." exact="influenza" post="B phylogenetic epidemiology surveillance victoria yamagata 1. Introduction Influenza"/>
  <result pre="year, an average of 772,000 respiratory hospitalizations is attributed to" exact="influenza" post="virus [2]. Although influenza A viruses (IAV) are responsible"/>
  <result pre="772,000 respiratory hospitalizations is attributed to influenza virus [2]. Although" exact="influenza" post="A viruses (IAV) are responsible for pandemics and they"/>
  <result pre="and they have major rates of hospitalization and mortality attribution," exact="influenza" post="B viruses (IBV) cause epidemics worldwide annually, becoming responsible"/>
  <result pre="in some years for more than 25% of human seasonal" exact="influenza" post="infections, and its prevention represents an important public health"/>
  <result pre="[6]. IBV were first identified in the 1940s and, unlike" exact="influenza" post="A, they primarily cause disease in humans [7]. Recurrent"/>
  <result pre="two lineages results in a different pattern of evolution of" exact="influenza" post="B virus and can explain some of the disparate"/>
  <result pre="antigenic drift than the more conserved Yamagata lineage [12]. Annual" exact="influenza" post="vaccination is the most effective method for preventing influenza"/>
  <result pre="Annual influenza vaccination is the most effective method for preventing" exact="influenza" post="and its associated complications. In general, seasonal vaccines are"/>
  <result pre="associated complications. In general, seasonal vaccines are trivalent, including one" exact="influenza" post="B lineage. Despite being only two lineages, the selection"/>
  <result pre="Despite being only two lineages, the selection of the right" exact="influenza" post="B virus strain in the vaccine has been proven"/>
  <result pre="as determine the age groups that are associated with both" exact="influenza" post="B lineages and surveillance type. In addition, we evaluated"/>
  <result pre="In addition, we evaluated the concordance between the predominant circulating" exact="influenza" post="B lineage and the B lineage included in the"/>
  <result pre="hospitalized patients with severe acute respiratory infection (SARI) associated with" exact="influenza" post="and 455 outpatients with clinical evidence of influenza-like illness"/>
  <result pre="Response System (GISRS) for the purposes of global surveillance of" exact="influenza" post="under the WHO Global Influenza Program, neither written informed"/>
  <result pre="p-value &amp;lt; 0.05 was considered statistically significant. The proportion of" exact="influenza" post="B positives among influenza virus positive specimens was separately"/>
  <result pre="considered statistically significant. The proportion of influenza B positives among" exact="influenza" post="virus positive specimens was separately determined in all years"/>
  <result pre="also determined among specimens that could be typed. Comparisons of" exact="influenza" post="B lineages distribution by age were completed by the"/>
  <result pre="statistically significant. In addition, we examined the proportion of each" exact="influenza" post="B lineage across different age groups in the study."/>
  <result pre="RNA mini kit (Qiagen), according to the manufacturer´s suggested protocol.The" exact="influenza" post="B positive specimens previously typified were distinguished into influenza"/>
  <result pre="protocol.The influenza B positive specimens previously typified were distinguished into" exact="influenza" post="B Victoria and Yamagata lineages by RT-PCR assay. Real"/>
  <result pre="hundred sequences. HA and NA nucleotide sequences of the Uruguayan" exact="influenza" post="B viruses generated in this study have been deposited"/>
  <result pre="sentinel surveillance. Of these specimens, 217 (3.8%) were confirmed for" exact="influenza" post="B virus by real-time RT-PCR. During the entire study"/>
  <result pre="in children and teenagers with more than 60% of total" exact="influenza" post="B infections. Those between 5–14 years had the highest"/>
  <result pre="observed two main circulation peaks being the positive rate of" exact="influenza" post="B viruses of SARI patients highest in children &amp;lt;4"/>
  <result pre="of the eight years of the study, the proportion of" exact="influenza" post="B found was significantly higher than that observed among"/>
  <result pre="Influenza A and B Viruses Fluctuations in the prevalence of" exact="influenza" post="A and B were observed during 2012–2019. Overall, 14.6%"/>
  <result pre="and B were observed during 2012–2019. Overall, 14.6% were confirmed" exact="influenza" post="cases, of which 36.9% (311/843), 37.4 % (315/843), and"/>
  <result pre="which 36.9% (311/843), 37.4 % (315/843), and 25.7% (217/843) were" exact="influenza" post="A/H1N1 pdm09, A/H3N2, and B infections, respectively. Influenza B"/>
  <result pre="and B infections, respectively. Influenza B viruses rarely dominate over" exact="influenza" post="A viruses, however in 2012, 2015, and 2017 there"/>
  <result pre="2012, 2015, and 2017 there was an important circulation of" exact="influenza" post="B viruses, reaching 40%, 58% and 47%, respectively, of"/>
  <result pre="viruses, reaching 40%, 58% and 47%, respectively, of the circulating" exact="influenza" post="virus. The co-circulation of influenza A/H3N2 and B was"/>
  <result pre="47%, respectively, of the circulating influenza virus. The co-circulation of" exact="influenza" post="A/H3N2 and B was observed in almost all of"/>
  <result pre="2018). However, in 2013 and 2016, the lowest incidence of" exact="influenza" post="B virus infection was detected (2.8% and 4.5%, respectively),"/>
  <result pre="(2.8% and 4.5%, respectively), along with the highest incidence of" exact="influenza" post="A/H1N1 pdm09 (78% and 95%, respectively) (Figure 2). 3.4."/>
  <result pre="different to the lineage that was included in the trivalent" exact="influenza" post="vaccine (TIV) for that season. A partial mismatch was"/>
  <result pre="only B/Victoria strains were detected. On average, 28% of circulating" exact="influenza" post="B was mismatched to recommended influenza B vaccine strain"/>
  <result pre="average, 28% of circulating influenza B was mismatched to recommended" exact="influenza" post="B vaccine strain during 2012, 2013, and 2015. During"/>
  <result pre="B/Yamagata lineage, respectively, to identify the lineage of the 217" exact="influenza" post="B viruses circulating in Uruguay during 2012–2019. The remaining"/>
  <result pre="not be subtyped. Forty-one samples were randomly selected from 208" exact="influenza" post="B virus for further HA and NA genetic analyses."/>
  <result pre="from 39/41 of the selected samples. Additional 24 Uruguayan HA" exact="influenza" post="B sequences were obtained from GISAID database. Hence, a"/>
  <result pre="obtained from GISAID database. Hence, a total of 63 HA" exact="influenza" post="B sequences from 208 positive samples from 2012 to"/>
  <result pre="the 2014 and 2018 seasons. Victoria Lineage Our 2012–2017 Uruguayan" exact="influenza" post="B/Victoria HA sequences were grouped in clade 1A, together"/>
  <result pre="of N129G, I180V (Figure 4). Yamagata Lineage Our 2012–2019 Uruguayan" exact="influenza" post="B/Yamagata HA sequences clustered into two distinguishable genetic clades:"/>
  <result pre="27/41 of the selected samples. An additional 24 Uruguayan NA" exact="influenza" post="B sequences were obtained from GISAID database. Hence, a"/>
  <result pre="obtained from GISAID database. Hence, a total of 51 NA" exact="influenza" post="B sequences from 208 positive samples from 2012 to"/>
  <result pre="NA K371Q amino acid substitution (Table S4). Our 2012–2019 Uruguayan" exact="influenza" post="Yamagata-lineage NA sequences clustered into two distinguishable genetic clades:"/>
  <result pre="several important conserved residues in the NA active site of" exact="influenza" post="B virus [22]. The NA protein of influenza B"/>
  <result pre="site of influenza B virus [22]. The NA protein of" exact="influenza" post="B has eight catalytic residues (R116, D149, R150, R223,"/>
  <result pre="lineages according to HA gene due to the possibility that" exact="influenza" post="viruses undergo gene reassortment. Although the classification of the"/>
  <result pre="host cells. Using inhibitors to block the cleavage function of" exact="influenza" post="NA does not avoid disease, but it treats influenza"/>
  <result pre="of influenza NA does not avoid disease, but it treats" exact="influenza" post="disease and might shorten the symptoms. We analyzed the"/>
  <result pre="Uruguayan NA sequences from original clinical samples had substitutions for" exact="influenza" post="B virus resistance to NA inhibitors, which suggested that"/>
  <result pre="use might still be suitable as a first-line treatment of" exact="influenza" post="B infections in Uruguay. 4. Discussion Until the present"/>
  <result pre="information regarding the epidemiology and genetic characteristics of the circulating" exact="influenza" post="B viruses in Uruguay [26,27]. On average, influenza B"/>
  <result pre="the circulating influenza B viruses in Uruguay [26,27]. On average," exact="influenza" post="B viruses accounted for approximately 26% of influenza positive"/>
  <result pre="On average, influenza B viruses accounted for approximately 26% of" exact="influenza" post="positive cases during 2012–2019. These results were similar to"/>
  <result pre="These results were similar to other countries that suggest that" exact="influenza" post="B virus contribute significantly to influenza disease [3,28,29,30,31,32,33]. Our"/>
  <result pre="countries that suggest that influenza B virus contribute significantly to" exact="influenza" post="disease [3,28,29,30,31,32,33]. Our findings revealed that types A and"/>
  <result pre="disease [3,28,29,30,31,32,33]. Our findings revealed that types A and B" exact="influenza" post="viruses almost always co-circulated throughout 2012–2019 and they confirm"/>
  <result pre="co-circulated throughout 2012–2019 and they confirm the important role of" exact="influenza" post="B virus in the spread of infection in the"/>
  <result pre="Glezen P and colleagues [4], it was suggested that when" exact="influenza" post="B activity is intense, it can produce an impact"/>
  <result pre="can produce an impact that is similar to that of" exact="influenza" post="A. Influenza B viruses rarely dominate in a season,"/>
  <result pre="in a season, however in 2015, in Uruguay, predominated over" exact="influenza" post="A. The increase of influenza B incidence also coincided"/>
  <result pre="2015, in Uruguay, predominated over influenza A. The increase of" exact="influenza" post="B incidence also coincided with a shift in the"/>
  <result pre="B incidence also coincided with a shift in the predominant" exact="influenza" post="B lineage (from the Yamagata lineage in 2014 to"/>
  <result pre="in 2014). In 2013 and 2016, the lowest incidence of" exact="influenza" post="B virus infection was detected in Uruguay, along with"/>
  <result pre="was detected in Uruguay, along with the highest incidence of" exact="influenza" post="A/H1N1 pdm09. The absence of influenza B viruses in"/>
  <result pre="the highest incidence of influenza A/H1N1 pdm09. The absence of" exact="influenza" post="B viruses in some season is not unusual, since"/>
  <result pre="unusual, since it is known that the activity of the" exact="influenza" post="B virus is highly variable worldwide, without an established"/>
  <result pre="lineages could be related to the genetic variability of the" exact="influenza" post="B virus [34,35,36]. In some years, influenza B viruses"/>
  <result pre="variability of the influenza B virus [34,35,36]. In some years," exact="influenza" post="B viruses represent strong bottlenecks in the population and"/>
  <result pre="and they are generally associated with a high prevalence of" exact="influenza" post="A virus [37,38]. Interaction with the influenza A virus"/>
  <result pre="high prevalence of influenza A virus [37,38]. Interaction with the" exact="influenza" post="A virus might be central in the configuration of"/>
  <result pre="central in the configuration of the evolutionary dynamics of the" exact="influenza" post="B virus and therefore facilitate the change in the"/>
  <result pre="B lineages in different age groups. Regarding the distribution of" exact="influenza" post="B viruses in relation to the surveillance type, the"/>
  <result pre="well known that SARI cases in children could lead to" exact="respiratory failure." post="Respiratory Sincitial Virus (RSV) and human Metapneumovirus (hMPV) significantly"/>
  <result pre="[47,48]. The finding from ILI sentinel sites revealed that the" exact="influenza" post="positivity rate was high among children aged 5–9 years"/>
  <result pre="of the eight years of the study, the proportion of" exact="influenza" post="B found was significantly higher than the observed among"/>
  <result pre="across different groups of age. Some studies have demonstrated that" exact="influenza" post="played an important role in the viral aetiologies of"/>
  <result pre="Phylogenetic analysis indicated that the HA and NA sequences of" exact="influenza" post="B virus could be divided in two distinct lineages:"/>
  <result pre="[21,55]. Insertions or deletions within the 160-loop region might enable" exact="influenza" post="B virus to survive longer without undergoing an antigenic"/>
  <result pre="years after 2012 would be somehow confirming the slowly evolving" exact="influenza" post="B/Yamagata viruses. In some of the years studied, amino"/>
  <result pre="and severity of the disease [63]. The selection of the" exact="influenza" post="B virus strain for the annual trivalent vaccine is"/>
  <result pre="predominant circulating lineage [26,65,66]. Indeed, we show here, that both" exact="influenza" post="B lineages circulated almost 2012–2019, in different proportions. Mismatches"/>
  <result pre="observed in 2015. Our data showed that 28% of the" exact="influenza" post="B infections that circulated in Uruguay did not correspond"/>
  <result pre="and the findings highlighted the effect on the epidemiology of" exact="influenza" post="viruses. Furthermore, it was reported that the vaccine efficacy"/>
  <result pre="viruses. Furthermore, it was reported that the vaccine efficacy for" exact="influenza" post="B was highly reduced when the circulating lineage was"/>
  <result pre="the magnitude of the impact of seasonal vaccine mismatch on" exact="influenza" post="epidemiology depends on several factors during a given season"/>
  <result pre="factors during a given season and the proportion of each" exact="influenza" post="B virus lineage circulating, as reported by Reed and"/>
  <result pre="so far, only a few countries actually recommend the Quadrivalent" exact="influenza" post="vaccination providing the vaccine free of charge [69]. Although"/>
  <result pre="heterogeneity and genetic information for estimating the variability of circulating" exact="influenza" post="B viruses in Uruguay and the neighboring countries. Further"/>
  <result pre="resistance, are needed. Despite the limitations, the surveillance system for" exact="influenza" post="B viruses has been proven useful to describe the"/>
  <result pre="proven useful to describe the epidemiological and evolutionary behavior of" exact="influenza" post="B viruses that have circulated in Uruguay during the"/>
  <result pre="the first to highlight the prevalence and molecular characteristics of" exact="influenza" post="B virus strains, especially the hemagglutinin and neuraminidase genes,"/>
  <result pre="like those other studies, confirm the genetic variability of the" exact="influenza" post="B viruses and show the importance of systematic epidemiological"/>
  <result pre="systematic epidemiological and molecular surveillance for the effective management of" exact="influenza" post="epidemics. Understanding the different evolutionary behavior of the influenza"/>
  <result pre="of influenza epidemics. Understanding the different evolutionary behavior of the" exact="influenza" post="viruses, and how they might interact, is clearly of"/>
  <result pre="the Americas, 2010-2015PLoS ONE201910.1371/journal.pone.022147931490961 3.CainiS.AlonsW.J.BalmasedaA.BrunoA.BustosP.CastilloL.de LozanoC.de MoraD.FasceR.FerreriraW.et al.Characteristics of seasonal" exact="influenza" post="A and B in Latin America: Influenza surveillance data"/>
  <result pre="Influenza surveillance data from ten countriesPLoS ONE201710.1371/journal.pone.017459228346498 4.PaulG.W.SchmierJ.K.KuehnC.M.RyanK.J.OxfordJ.The burden of" exact="influenza" post="B: A structured literature reviewAm. J. Public Health.201310.2105/AJPH.2012 5.JenningsL.HuangQ.BarrI.LeeP.KimW.J.BuchyP.SanicasM.MungalyB.ChenJ.Literature"/>
  <result pre="reviewAm. J. Public Health.201310.2105/AJPH.2012 5.JenningsL.HuangQ.BarrI.LeeP.KimW.J.BuchyP.SanicasM.MungalyB.ChenJ.Literature review of the epidemiology of" exact="influenza" post="B disease in 15 countries in the Asia-Pacific regiónInfluenza"/>
  <result pre="Viruses20181238341110.1111/irv.1252229127742 6.SuS.ChavesS.S.PerezA.D´MelloT.KirleyP.D.YOusey-HindesK.FarleyM.M.HarrisM.SharangpaniR.LynfieldR.et al.Comparing clinical characteristics between hospitalized adults with laboratory-confirmed" exact="influenza" post="A and B infectionClin. Infect. Dis.20145925225510.1093/cid/ciu26924748521 7.Francis T.Jr.A new"/>
  <result pre="7.Francis T.Jr.A new type of virus from epidemic influenzaScience19409240540810.1126/science.92.2392.40517794275 8.BedfordT.SuchardM.A.LemeyP.DudasG.GregoryV.HayA.J.McCaulleyJ.W.RussellC.A.SmithD.J.RambautA.Integrating" exact="influenza" post="antigenic dynamics with molecular evolutionElife201410.7554/eLife.01914 9.RotaP.A.WallisT.R.HarmonM.W.RotaJ.S.KendalA.P.NeromeK.Cocirculation of two distinct"/>
  <result pre="with molecular evolutionElife201410.7554/eLife.01914 9.RotaP.A.WallisT.R.HarmonM.W.RotaJ.S.KendalA.P.NeromeK.Cocirculation of two distinct evolutionary lineages of" exact="influenza" post="type B virus since 1983Virology1990175596810.1016/0042-6822(90)90186-U2309452 10.LoY.-C.ChuangJ.-H.KuoH.-W.HuangW.T.HsuY.F.LiuM.T.ChenC.H.HuangH.H.ChangC.H.ChouJ.H.et al.Surveillance and vaccine"/>
  <result pre="virus since 1983Virology1990175596810.1016/0042-6822(90)90186-U2309452 10.LoY.-C.ChuangJ.-H.KuoH.-W.HuangW.T.HsuY.F.LiuM.T.ChenC.H.HuangH.H.ChangC.H.ChouJ.H.et al.Surveillance and vaccine effectiveness of an" exact="influenza" post="epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan,"/>
  <result pre="and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched" exact="influenza" post="B/Yamagata-lineage viruses in Taiwan, 2011–2012 seasonPLoS ONE20138e5822210.1371/journal.pone.005822223472161 11.ChenG.W.ShihS.R.HsiaoM.R.ChangS.C.LinS.H.SunC.F.TsaoK.C.Multiple genotypes"/>
  <result pre="B/Yamagata-lineage viruses in Taiwan, 2011–2012 seasonPLoS ONE20138e5822210.1371/journal.pone.005822223472161 11.ChenG.W.ShihS.R.HsiaoM.R.ChangS.C.LinS.H.SunC.F.TsaoK.C.Multiple genotypes of" exact="influenza" post="B viruses co-circulated in Taiwan in 2004 and 2005J."/>
  <result pre="and 2005J. Clin. Microbiol.2007451515152210.1128/JCM.02189-0617329451 12.VijaykrishnaD.HolmesE.C.JosephU.FourmentM.SuY.C.HalpinR.LeeR.T.DengY.M.GunalanV.LinX.et al.The contrasting phylodynamics of human" exact="influenza" post="B virusesElife20154e0505510.7554/eLife.0505525594904 13.BeranJ.WertzovaV.HonegrK.KaliskovaE.HavlickovaM.HavlikJ.JirincovaH.Van BelleP.JainV.InnisB.et al.Challenge of conducting a placebo-controlled"/>
  <result pre="BelleP.JainV.InnisB.et al.Challenge of conducting a placebo-controlled randomized efficacy study for" exact="influenza" post="vaccine in a season with low attack rate and"/>
  <result pre="15.collab: World Health OrganizationWHO information for the molecular detection of" exact="influenza" post="virusesUpdated July, 20172017Available online: https://www.who.int/influenza/gisrs_laboratory/WHO_information_for_the_molecular_detection_of_influenza_viruses_20171023_Final.pdf(accessed on 20 January 2020)"/>
  <result pre="2020) 16.collab: World Health OrganizationWHO recommendations on the composition of" exact="influenza" post="virus vaccinesAvailable online: https://www.who.int/influenza/vaccines/virus/recommendations/en/(accessed on 20 January 2020) 17.TamuraK.StecherG.PetersonD.FilipskiA.KumarS.MEGA"/>
  <result pre="phylogenies: An approach using the bootstrapEvolution19853978379110.1111/j.1558-5646.1985.tb00420.x28561359 21.WangQ.ChengF.LuM.TianX.MaJ.Crystal structure of unliganded" exact="influenza" post="B virus hemagglutininJ. Virol.2008823011302010.1128/JVI.02477-0718184701 22.ColmanP.M.VargheseJ.N.LaverW.G.Structure of the catalytic and"/>
  <result pre="hemagglutininJ. Virol.2008823011302010.1128/JVI.02477-0718184701 22.ColmanP.M.VargheseJ.N.LaverW.G.Structure of the catalytic and antigenic sites in" exact="influenza" post="virus neuraminidaseNature1983303414410.1038/303041a06188957 23.TewawongN.SuwannakarnK.PrachayangprechaS.KorkongS.VichiwattanaP.VongpunsawadS.PoovorawanY.Molecular epidemiology and phylogenetic analyses of influenza"/>
  <result pre="in influenza virus neuraminidaseNature1983303414410.1038/303041a06188957 23.TewawongN.SuwannakarnK.PrachayangprechaS.KorkongS.VichiwattanaP.VongpunsawadS.PoovorawanY.Molecular epidemiology and phylogenetic analyses of" exact="influenza" post="B virus in Thailand during 2010 to 2014PLoS ONE201510e011630210.1371/journal.pone.011630225602617"/>
  <result pre="24.GubarevaL.MatrosovichM.N.BrennerM.K.BethellR.C.WebsterR.G.Evidence for zanamivir resistance in an immunocompromised child infected with" exact="influenza" post="B virusJ. Infect. Dis.19981781257126210.1086/3144409780244 25.collab: WHOLaboratory methodologies for testing"/>
  <result pre="Dis.19981781257126210.1086/3144409780244 25.collab: WHOLaboratory methodologies for testing the antiviral susceptibility of" exact="influenza" post="viruses: Neuraminidase inhibitor (NAI)A summary of amino acid substitutions"/>
  <result pre="Neuraminidase inhibitor (NAI)A summary of amino acid substitutions in the" exact="influenza" post="neuraminidase associated with resistance or reduced susceptibility to NAIsAvailable"/>
  <result pre="from UruguayRev. Infect. Dis.199012S995S99710.1093/clinids/12.Supplement_8.S9952270420 28.PalekarR.RodriguezA.AvilaC.BarreraG.BarreraM.BrenesH.BrunoA.El OmeiriN.FasceR.Ferreira de AlmeidaW.et al.Patterns of" exact="influenza" post="B circulation in Latin America and the Caribbean, 2010–2017PLoS"/>
  <result pre="in Latin America and the Caribbean, 2010–2017PLoS ONE201914e021959510.1371/journal.pone.021959531393886 29.TranD.VaudryW.MooreD.BettingerJ.A.HalperinS.A.ScheifeleD.W.JadvjiT.LeeL.MersereauT.Hospitalization for" exact="influenza" post="A. versus BPediatrics201610.1542/peds.2015-4643 30.SelekaM.TreurnichtF.K.TempiaS.HellfersceeO.MtshaliS.CohenA.L.BuysA.McAnerneyJ.M.BesselaarT.G.PretoriusM.et al.Epidemiology of influenza B/Yamagata and"/>
  <result pre="ONE201914e021959510.1371/journal.pone.021959531393886 29.TranD.VaudryW.MooreD.BettingerJ.A.HalperinS.A.ScheifeleD.W.JadvjiT.LeeL.MersereauT.Hospitalization for influenza A. versus BPediatrics201610.1542/peds.2015-4643 30.SelekaM.TreurnichtF.K.TempiaS.HellfersceeO.MtshaliS.CohenA.L.BuysA.McAnerneyJ.M.BesselaarT.G.PretoriusM.et al.Epidemiology of" exact="influenza" post="B/Yamagata and B/Victoria lineages in south africa, 2005-2014PLoS ONE201710.1371/journal.pone.0177655"/>
  <result pre="south africa, 2005-2014PLoS ONE201710.1371/journal.pone.0177655 31.CainiS.HuangQ.S.CiblakM.A.KusznierzG.OwenR.WangchukS.HenriquesC.M.NjouomR.FasceR.A.YuH.et al.Epidemiological and virological characteristics of" exact="influenza" post="B: Results of the Global Influenza B StudyInfluenza Other"/>
  <result pre="Influenza B StudyInfluenza Other Respir. Viruses2015931210.1111/irv.1231926256290 32.BarrI.G.VijaykrishnaD.SullivanS.G.Differential age susceptibility to" exact="influenza" post="B/Victoria lineage viruses in the 2015 Australian influenza seasonEuro"/>
  <result pre="susceptibility to influenza B/Victoria lineage viruses in the 2015 Australian" exact="influenza" post="seasonEuro Surveill.201610.2807/1560-7917.ES.2016.21.4.30118 33.GlezenW.P.Changing Epidemiology of Influenza B VirusClin. Infect."/>
  <result pre="Dis.2014591525152610.1093/cid/ciu66825139967 34.McCullersJ.A.WangG.C.HeS.WebsterR.G.Reassortment and insertion-deletion are strategies for the evolution of" exact="influenza" post="B viruses in natureJ. Virol.1999737343734810.1128/JVI.73.9.7343-7348.199910438823 35.BakerS.F.NogalesA.FinchC.TuffyK.M.DommW.PerezD.R.TophamD.J.Martínez-SobridoL.Influenza A and B"/>
  <result pre="intertypic reassortment through compatible viral packaging signalsJ. Virol.201488107781079110.1128/JVI.01440-1425008914 36.DudasG.BedfordT.LycettS.RambautA.Reassortment between" exact="influenza" post="B lineages and the emergence of a co adapted"/>
  <result pre="PB1-PB2-HA gene complexMol. Biol. Evol.20143216217210.1093/molbev/msu28725323575 37.YangJ.R.HuangY.P.ChangF.Y.HsuL.C.LinY.C.HuangH.Y.WuF.T.WuH.S.LiuM.T.Phylogenetic and evolutionary history of" exact="influenza" post="B viruses, which caused a large epidemic in 2011-2012,"/>
  <result pre="epidemic in 2011-2012, TaiwanPLoS ONE20127e4717910.1371/journal.pone.004717923071751 38.ChenR.HolmesE.C.The evolutionary dynamics of human" exact="influenza" post="B virusJ. Mol. Evol.20086665566310.1007/s00239-008-9119-z18504518 39.LangatP.RaghwaniJ.DudasG.BowdenT.A.EdwardsS.GallA.BedfordT.RambautA.DanielsR.S.RussellC.et al.Genome-wide evolutionary dynamics of"/>
  <result pre="influenza B virusJ. Mol. Evol.20086665566310.1007/s00239-008-9119-z18504518 39.LangatP.RaghwaniJ.DudasG.BowdenT.A.EdwardsS.GallA.BedfordT.RambautA.DanielsR.S.RussellC.et al.Genome-wide evolutionary dynamics of" exact="influenza" post="B viruses on a global scalePLoS Pathog.201710.1371/journal.ppat.1006749 40.TsedenbalN.Tsend-AyushA.BadarchD.JavS.PagbajabN.Influenza B"/>
  <result pre="years in MongoliaPLoS ONE201810.1371/journal.pone.0206987 41.HorthongkhamN.AthipanyasilpN.PattamaA.KaewnapanB.SornprasertS.SrisurapanontS.KantakamalakulW.AmaranondP.SutthentR.Epidemiological, Clinical and Virological characteristics of" exact="influenza" post="B virus from patients at the hospital Tertary care"/>
  <result pre="2011–2014PLoS ONE201610.1371/journal.pone.0158244 42.TrucchiC.AlicinoC.OrsiA.PaganinoC.BarberisI.GrammaticoF.CanepaP.RappazzoE.BruzzoneB.SticchiL.et al.Fifteen years of epidemiologic, virologic and syndromic" exact="influenza" post="surveillance: A focus on type B virus and the"/>
  <result pre="mismatch in Liguria region, ItalyHum.Vaccin. Immunother.20171345646310.1080/21645515.2017.126477927924684 43.TanY.GuanW.LamT.T.PanS.WuS.ZhanY.ViboudC.HolmesE.C.YangZ.Differing epidemiological dynamics of" exact="influenza" post="B virus lineages in Guangzhou, Southern China,2009-2010J. Virol.201387124471245610.1128/JVI.01039-1324027322 44.CainiS.KusznierzG.GarateV.V.WangchukS.ThapaB.de"/>
  <result pre="Virol.201387124471245610.1128/JVI.01039-1324027322 44.CainiS.KusznierzG.GarateV.V.WangchukS.ThapaB.de Paula JúniorF.J.Ferreira de AlmeidaW.A.NjouomR.FasceR.A.BustosP.et al.The epidemiological signature of" exact="influenza" post="B virus and its B/Victoria and B/Yamagata lineages in"/>
  <result pre="in the 21 st centuryPLoS ONE201910.1371/journal.pone.0222381 45.OrsiA.ColombaG.M.E.PojeroF.CalamusaG.AlicinoC.TrucchiC.CanepaP.AnsaldiF.VitaleF.TramutoF.Trends of impact of" exact="influenza" post="B during the 2010-2016 seasons in 2 regions of"/>
  <result pre="and south italy: The impact of the vaccine mismatch on" exact="influenza" post="immunization strategyHum. Vaccin. Immunother.20181452353110.1080/21645515.2017.134290728708953 46.ChengW.YuZ.LiuS.ZhangX.WangX.CaiJ.LingF.ChenE.Comparison of influenza epidemiological and"/>
  <result pre="vaccine mismatch on influenza immunization strategyHum. Vaccin. Immunother.20181452353110.1080/21645515.2017.134290728708953 46.ChengW.YuZ.LiuS.ZhangX.WangX.CaiJ.LingF.ChenE.Comparison of" exact="influenza" post="epidemiological and virological characteristics between outpatients and inpatients in"/>
  <result pre="2015Int. J. Env. Res. Public Health201721710.3390/ijerph1402021728241447 47.BurmaaA.KamigakiT.DarmaaB.NymadawaP.OshitaniH.Epidemiology and impact of" exact="influenza" post="in Mongolia 2007–2012Influenza Other Respir. Viruses2014853053710.1111/irv.1226825043147 48.TalloV.L.KamigakiT.TanA.G.Estimating influenza outpatient´s"/>
  <result pre="impact of influenza in Mongolia 2007–2012Influenza Other Respir. Viruses2014853053710.1111/irv.1226825043147 48.TalloV.L.KamigakiT.TanA.G.Estimating" exact="influenza" post="outpatient´s and impatients incidences from 2009 to 2011 in"/>
  <result pre="Shangai, China, 2011 to 2013PLoS ONE201510.1371/journal.pone.0119513 50.NohJ.SongJ.Y.CheongH.J.ChoiW.S.LeeJ.LeeJ.S.WieS.H.JeongH.W.KimY.K.ChoiS.H.et al.Laboratory surveillance of" exact="influenza" post="–like illness in seven teaching hospitals, South Koreal: 2011–2012"/>
  <result pre="infections in ChinaPLoS ONE20138e7260610.1371/journal.pone.007260623991128 52.collab: World Health OrganizationRecommended composition of" exact="influenza" post="virus vaccines for use in the 2018–2019 northern hemisphere"/>
  <result pre="influenza virus vaccines for use in the 2018–2019 northern hemisphere" exact="influenza" post="seasonWkly Epidemiol. Rec.20189313315229569429 53.KuoS.ChenG.W.VeluA.B.DashS.HanY.J.TsaoK.C.ShihS.R.Circulating pattern and genomic characteristics of"/>
  <result pre="influenza seasonWkly Epidemiol. Rec.20189313315229569429 53.KuoS.ChenG.W.VeluA.B.DashS.HanY.J.TsaoK.C.ShihS.R.Circulating pattern and genomic characteristics of" exact="influenza" post="B viruses in Taiwan from 2003 to 2014J. Formos."/>
  <result pre="2003 to 2014J. Formos. Med. Assoc.201611551052210.1016/j.jfma.2016.01.01727038555 54.ShenJ.KirkB.D.MaJ.WangQ.Diversifying selective pressure on" exact="influenza" post="B virus hemagglutininJ. Med. Virol.20098111412410.1002/jmv.2133519031453 55.TramutoF.OrsiA.MaidaC.M.CostantinoC.TrucchiC.AlicinoC.VitaleF.AnsaldiF.The molecular epidemiology and"/>
  <result pre="hemagglutininJ. Med. Virol.20098111412410.1002/jmv.2133519031453 55.TramutoF.OrsiA.MaidaC.M.CostantinoC.TrucchiC.AlicinoC.VitaleF.AnsaldiF.The molecular epidemiology and evolutionary dynamics of" exact="influenza" post="B virus in two italian regions during 2010-2015: The"/>
  <result pre="of Sicily and LiguriaInt. J. Mol. Sci.20161754910.3390/ijms1704054927089319 56.NeromeR.HiromotoY.SugitaS.TanabeN.IshidaM.MatsumotoM.LindstromS.E.TakahashiT.NeromeK.Evolutionary characteristics of" exact="influenza" post="B virus since its first isolation in 1940: Dynamic"/>
  <result pre="and insertion mechanismArch. Virol.19981431569158310.1007/s0070500503999739335 57.SuptawiwatO.NinpanK.BoonarkartC.RuangrungK.AuewarakulP.Evolutionary dynamic of antigenic residues on" exact="influenza" post="B hemagglutininVirology2017502849610.1016/j.virol.2016.12.01528024225 58.McAuleyJ.GilbertsonB.TrifkovicS.BrownL.McKimm-BreschkinJ.L.Influenza virus neuraminidase structure and functionsFront. Microbiol.201910.3389/fmicb.2019.00039"/>
  <result pre="structure and functionsFront. Microbiol.201910.3389/fmicb.2019.00039 59.LinY.P.GregoryV.CollinsP.KloessJ.WhartonS.CattleN.LackenbyA.DanielsR.HayA.Neuraminidase receptor binding variants of human" exact="influenza" post="A(H3N2) viruses resulting from substitution of aspartic acid 151"/>
  <result pre="in virus attachment?J. Virol.2010846769678110.1128/JVI.00458-1020410266 60.MohrP.G.DengY.M.McKimm-BreschkinJ.L.The neuraminidases of MDCK grown human" exact="influenza" post="A (H3N2) viruses isolated since 1994 can demonstrate receptor"/>
  <result pre="can demonstrate receptor bindingVirol. J.201510.1186/s12985-015-0295-3 61.TivaneA.DanielsR.NguenhaN.MachaleleL.NacotoA.PaleM.MateonaneE.MavaleS.ChilundoJ.MutetoD.Antigenic and genetic characterization of" exact="influenza" post="viruses isolated in Mozambique during the 2015 seasonPLoS ONE201810.1371/journal.pone.0201248"/>
  <result pre="vaccine lineage selection-an optimized trivalent vaccineVaccine2016341617162210.1016/j.vaccine.2016.01.04226896685 64.DemicheliV.JeffersonT.FerroniE.RivettA.Di PietrantonjC.Vaccines for preventing" exact="influenza" post="in healthy adultsCochrane Database Syst. Rev.201810.1002/14651858.CD001269.pub6 65.QinY.ZhangY.WuP.Influenza vaccine effectiveness"/>
  <result pre="preventing hospitalization among Beijing residents in China, 2013–2015Vaccine2016342329233310.1016/j.vaccine.2016.03.06827026147 66.MoaA.M.MuscatelloD.J.TurnerR.M.MacIntyreC.R.Epidemiology of" exact="influenza" post="B in Australia: 2001-2014Influenza Other Respir. Viruses20171110210910.1111/irv.1243227650482 67.TinocoY.O.Azziz-BaumgartnerE.UyekT.M.Burden of"/>
  <result pre="surveillance of a community cohort, 2009-2015Clin. Infect. Dis.2017651532154110.1093/cid/cix56529020267 68.ReedC.ChavesS.S.KirleyP.D.EmersonR.AragonD.HancockE.B.ButlerL.HollickG.BaumbachJ.HollickG.et al.Estimating" exact="influenza" post="disease burden from population-based surveillance data in the United"/>
  <result pre="online: http://vaccine-schedule.ecdc.europa.eu/Pages/Scheduler.aspx(accessed on 27 February 2019) Figure 1 Distribution of" exact="influenza" post="B viruses (IBV) cases in Uruguay according to age"/>
  <result pre="the different age groups are indicated. Figure 2 Incidence of" exact="influenza" post="A and B viruses identified from clinical samples in"/>
  <result pre="Uruguay during 2012 to 2019. The year distribution of the" exact="influenza" post="viruses, including A (H1N1pdm09) (blue color), A(H3N2) (light blue)"/>
  <result pre="viruses, including A (H1N1pdm09) (blue color), A(H3N2) (light blue) and" exact="influenza" post="B (yellow color) activity. Figure 3 Circulation of influenza"/>
  <result pre="and influenza B (yellow color) activity. Figure 3 Circulation of" exact="influenza" post="B lineages according to season (year) and recommended vaccine"/>
  <result pre="indicated, and &quot;Yes�? or &quot;No�? if they coincide with the" exact="influenza" post="B strains that have circulated. Abbreviations V1A, V1A1, Y2,"/>
  <result pre="Figure 4 Phylogenetic analysis of the HA1 nucleotide sequences from" exact="influenza" post="B Victoria-lineage viruses circulating in Uruguay from 2012 to"/>
  <result pre="arrows. Figure 5 Phylogenetic analysis of HA1 nucleotide sequences from" exact="influenza" post="B Yamagata-lineage viruses circulating in Uruguay from 2012 to"/>
  <result pre="6 Phylogenetic analysis of the partial neuraminidase nucleotide sequences from" exact="influenza" post="B Victoria-lineage viruses circulating in Uruguay from 2012 to"/>
  <result pre="7 Phylogenetic analysis of the partial neuraminidase nucleotide sequences from" exact="influenza" post="B Yamagata-lineage viruses circulating in Uruguay from 2012 to"/>
  <result pre="are indicated with arrows. microorganisms-08-00591-t001_Table 1Table 1 Age distribution of" exact="influenza" post="B infections according to type of surveillance and influenza"/>
  <result pre="of influenza B infections according to type of surveillance and" exact="influenza" post="B lineages. Numbers of patients are indicated according to"/>
  <result pre="according to age group, discriminating by type of surveillance and" exact="influenza" post="B lineages between 2012–2019. Lineage determination in samples n"/>
 </snippets>
</snippetsTree>
